Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $112,425 | 12 | 98.6% |
| Travel and Lodging | $1,085 | 2 | 1.0% |
| Food and Beverage | $325.74 | 7 | 0.3% |
| Education | $157.32 | 29 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $109,200 | 10 | $0 (2024) |
| Travere Therapeutics, Inc. | $4,251 | 38 | $0 (2024) |
| AstraZeneca UK Limited | $525.00 | 1 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $17.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,086 | 30 | AstraZeneca Pharmaceuticals LP ($47,950) |
| 2023 | $51,628 | 5 | AstraZeneca Pharmaceuticals LP ($51,625) |
| 2022 | $14,236 | 12 | AstraZeneca Pharmaceuticals LP ($9,625) |
| 2021 | $42.83 | 3 | Travere Therapeutics, Inc. ($25.00) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 09/09/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 09/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 07/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 07/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 07/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 07/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Consulting Fee | Cash or cash equivalent | $12,075.00 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 05/22/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/10/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 05/10/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 05/01/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/19/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $15,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 03/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 212 | 384 | $194,790 | $46,233 |
| 2022 | 7 | 263 | 490 | $240,365 | $58,739 |
| 2021 | 7 | 287 | 651 | $349,300 | $88,787 |
| 2020 | 9 | 392 | 883 | $486,059 | $110,335 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 97 | 276 | $102,120 | $23,064 | 22.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 31 | 52 | $43,940 | $9,694 | 22.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 67 | 150 | $39,000 | $8,819 | 22.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 54 | 70 | $33,950 | $7,728 | 22.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 25 | 25 | $17,875 | $3,957 | 22.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 24 | 29 | $7,618 | $2,503 | 32.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 29 | $10,870 | $2,218 | 20.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 17 | $4,420 | $1,024 | 23.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 15 | $5,166 | $981.22 | 19.0% |
About Dr. Daniel Gray, MD
Dr. Daniel Gray, MD is a Nephrology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295779932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Gray, MD has received a total of $113,994 in payments from pharmaceutical and medical device companies, with $48,086 received in 2024. These payments were reported across 50 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($112,425).
As a Medicare-enrolled provider, Gray has provided services to 1,154 Medicare beneficiaries, totaling 2,408 services with total Medicare billing of $304,094. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Rochester, NY
- Active Since 06/15/2006
- Last Updated 07/05/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1295779932
Products in Payments
- LOKELMA (Drug) $97,650
- TEZSPIRE (Biological) $12,075
- JYNARQUE (Drug) $17.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Rochester
David Bushinsky, Md, MD
Nephrology — Payments: $172,916
Neera Dahl, Md, MD
Nephrology — Payments: $116,887
Fernando Fervenza, M.d, M.D
Nephrology — Payments: $87,112
Robert Mayo, M.d, M.D
Nephrology — Payments: $64,976
Leslie Wong, Md, MD
Nephrology — Payments: $64,754
John Lieske, M.d, M.D
Nephrology — Payments: $48,304